US Manufacturers Urge New York to Distribute American-Made Masks During Wildfire Emergency
New York, Friday, 17 July 2026.
As wildfire smoke blankets New York, domestic manufacturers are criticizing officials for distributing imported Chinese masks instead of utilizing a massive surplus of American-made respirators.
Wildfire Smoke Sparks Public Health and Trade Debate
A dense haze from Canadian wildfires has descended upon New York, prompting local health departments to issue urgent alerts and distribute protective gear to the public [2][3]. On July 15, 2026, Tompkins County Whole Health (TCWH) classified the local Air Quality Index (AQI) as “Unhealthy” and began distributing free N95 and KN95 respirators to protect residents from fine particulate matter [2]. However, this emergency response has quickly ignited a fierce economic debate. On July 16, 2026, the American Medical Manufacturers Association (AMMA) publicly criticized New York Governor Kathy Hochul and New York City Mayor Zohran Mamdani for distributing Chinese-made KN95 masks instead of prioritizing domestically manufactured, federally approved alternatives [1].
Contrasting Regulatory Standards
The core of the dispute lies in the regulatory and safety standards governing the protective equipment being distributed to citizens. According to AMMA, KN95 masks are certified under Chinese standards and rely on manufacturer self-certification [1]. In contrast, American-made N95 respirators must pass rigorous U.S. federal workplace safety testing and auditing requirements administered by the National Institute for Occupational Safety and Health (NIOSH) [1]. Beyond standard safety certifications, the reliance on imported Chinese masks introduces complex geopolitical and economic risks [1]. AMMA points out that these imports are currently subject to federal scrutiny under Section 301 investigations and proposed tariffs aimed at addressing forced labor within China’s manufacturing sector [1].
The Economic Cost of Foreign Procurement
From an economic perspective, domestic manufacturers argue that public procurement during emergencies should bolster, rather than undermine, the local industrial base [1]. Representatives from New York-based manufacturers, such as Altor Safety, HPK Industries, and New York Embroidery Studio, have expressed deep frustration over being bypassed during a local crisis [1]. Michelle Feinberg, CEO of New York Embroidery Studio, emphasized that while public mask distribution is positive, New York leadership should prioritize domestic NIOSH-approved N95 respirators when they are readily available [1]. Tom Allen, President of AMMA and CEO of Altor Safety, criticized the decision as a misuse of American taxpayer funds, arguing that public dollars should not underwrite foreign supply chains tied to human rights concerns [1].
Unused Capacity and the Made PPE in America Act
The controversy is further magnified by the substantial, yet underutilized, capacity of the domestic medical manufacturing sector. On July 15, 2026, AMMA reported that domestic manufacturers possess an annual production capacity of 435 million N95 respirators [1]. This capacity represents 96.667% of the estimated 450 million units required for routine annual U.S. demand [1]. Furthermore, during a public health crisis, these domestic facilities have the capability to scale up production to 1.5 billion units annually, which is 3.448 times their routine annual capacity [1]. AMMA is calling on Governor Hochul and Mayor Mamdani to align their emergency stockpiles with the federal Made PPE in America Act, urging a shift in procurement policy that supports American workers and guarantees supply chain resilience [1].